Monoclonal Antibodies: Global Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)

DUBLIN, July 5, 2018 /PRNewswire/ --

The "Global Monoclonal Antibodies Market - by Type, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The Global Monoclonal Antibodies Market was 95.1 Billion USD in 2017and is estimated to reach 131.33 Billion USD by 2023 with a CAGR of 5.53% during the period.

Growth by Region

North America region will dominate the market during the forecast period. This growth is due to the existence of good healthcare infrastructure and growing emphasis by government for infection control. On the other hand, Asia-Pacific will have the highest growth rate due to increase in the spending power of the people in this region along with increase in the spending on research.

Drivers vs. Constraints

    --  The increasing prevalence of cancer and other chronic diseases drive the
        growth of the Global Monoclonal Antibodies market. Rising awareness
        among patients and physicians on the applications of monoclonal
        antibodies also drive this market.
    --  Monoclonal antibodies drugs are very specific in nature with limited
        targets which restrict this market growth.

Industry Structure and Updates

Three major companies Abbott, Johnson & Johnson, and Roche launched three Monoclonal Antibody therapies which are today's leading therapies.

Key Topics Covered

1. Research Methodology

2. Executive Summary

3. Market Overview
3.1. Definition
3.2. Industry Value Chain Analysis
3.3. Porter's 5 Forces
3.4. Regulations

4. Market Dynamics
4.1. Introduction
4.2. Drivers
4.3. Constraints
4.4. Trends

5. Global Monoclonal Antibodies Market Segmentation, Forecasts and Trends - by Type
5.1. Naked mAbs
5.2. Conjugated mAbs

6. Global Monoclonal Antibodies Market Segmentation, Forecasts and Trends - by Applicaton
6.1. Oncology
6.2. Autoimmune and inflammatory diseases
6.3. Respiratory diseases
6.4. Ophthalmology
6.5. TNF inhibitors
6.6. IL-1 blockers
6.7. PDE4 inhibitors
6.8. Global respiratory mAbs market

7. Global Monoclonal Antibodies Market Segmentation, Forecasts and Trends - by Region
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.2. Europe
7.2.1. UK
7.2.2. France
7.2.3. Germany
7.2.4. Italy
7.2.5. Others
7.3. Asia-Pacific
7.3.1. India
7.3.2. China
7.3.3. Japan
7.3.4. Australia
7.3.5. Others
7.4. Latin America
7.4.1. Brazil
7.4.2. Argentina
7.4.3. Mexico
7.4.4. Others
7.5. Middle East and Africa
7.5.1. South Africa
7.5.2. UAE
7.5.3. Saudi Arabia
7.5.4. Egypt
7.5.5. Others

8. Company Market Share Analysis

9. Company Profiles
9.1. AbbVie
9.2. Amgen
9.3. Bristol-Myers Squibb
9.4. F. Hoffmann-La Roche
9.5. Johnson & Johnson
9.6. Merck
9.7. AbGenomics
9.8. ADC Therapeutics
9.9. Agensys
9.10. Alexion Pharmaceuticals
9.11. ALMAC Group
9.12. Ambrx
9.13. Astellas Pharma
9.14. AstraZeneca
9.15. Bayer HealthCare
9.16. Biogen
9.17. Celgene
9.18. Celldex Therapeutics
9.19. Daiichi Sankyo
9.20. Eisai
9.21. Eli Lilly
9.22. Formation Biologics
9.23. Genmab
9.24. GlaxoSmithKline
9.25. Human Genome Sciences
9.26. Others

10. Industry Structure
10.1. Industry M&As, Consolidations
10.2. Investment Opportunities

11. Global Monoclonal Antibodies Market - Road Ahead

12. Tables

For more information about this report visit https://www.researchandmarkets.com/research/38xx6t/monoclonal?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/monoclonal-antibodies-global-market-size-demand-forecasts-company-profiles-industry-trends-and-updates-2017-2023-300676365.html

SOURCE Research and Markets